Phi Therapeutics, Inc. — Form D
Phi Therapeutics, Inc. of PETALUMA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-06. The offering totals $7.7M, of which $4.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-04-06
- Form: D
- Accession: 0001778492-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.7M
- Amount sold: $4.2M
- Remaining: $3.5M
- Minimum investment: $10K
- Investors: 16
- Date of first sale: 2023-03-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-478065
Issuer
- Name: Phi Therapeutics, Inc.
- CIK: 0001778492
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1250 PETALUMA BLVD N, PETALUMA, CA, 94952
- Phone: 707-243-8820
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| JUN LI | Director | PETALUMA, CA |
| YUG VARMA | Director | PETALUMA, CA |
| YUG VARMA | Executive Officer | PETALUMA, CA |
| YUG VARMA | Promoter | PETALUMA, CA |
| NEIL GIUGNO | Director | PETALUMA, CA |
| NEIL GIUGNO | Executive Officer | PETALUMA, CA |
| KEVIN LAW | Director | PETALUMA, CA |
| Maria Cho | Director | Emeryville, CA |
| Maria Cho | Promoter | Emeryville, CA |
| Maria S Cho | Director | San Francisco, CA |
| Maria S Cho | Executive Officer | San Francisco, CA |
| Jun S Li | Director | Palo Alto, CA |
Other filings by this issuer (3)
More